1 The relationship of RSV-specific immunoglobulin E antibody responses in infancy, recurrent wheezing, and pulmonary function at age 7-8 years

2 Evaluation of the protective efficacy of reshaped human monoclonal antibody RSHZ19 against respiratory syncytial virus in cotton rats

3 An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine

4 Passive transfer of respiratory syncytial virus (RSV) antiserum suppresses the immune response to the RSV fusion (F) and large (G) glycoproteins expressed by recombinant vaccinia viruses

5 Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine

6 Respiratory syncytial virus infection in C57BL/6 mice: clearance of virus from the lungs with virus-specific cytotoxic T cells

7 Respiratory syncytial virus infection enhances neutrophil and eosinophil adhesion to cultured respiratory epithelial cells. Roles of CD18 and intercellular adhesion molecule-1

8 Reinfection of mice with respiratory syncytial virus

9 Analysis of the local and systemic immune responses induced in BALB/c mice by experimental respiratory syncytial virus infection

10 Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin

11 Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection

12 Age related IgG subclass response to respiratory syncytial virus fusion protein in infected infants

13 Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived

14 Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization

15 Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus

16 Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60

17 Effect of ribavirin therapy on respiratory syncytial virus-specific IgE and IgA responses after infection

18 Resistance to respiratory syncytial virus (RSV) challenge induced by infection with a vaccinia virus recombinant expressing the RSV M2 protein (Vac-M2) is mediated by CD8+ T cells, while that induced by Vac-F or Vac-G recombinants is mediated by antibodies

19 Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis

20 Enzyme-linked immunosorbent assay for measurement of serological response to respiratory syncytial virus infection

21 Monoclonal antibodies to respiratory syncytial virus proteins: identification of the fusion protein

22 Immunopathologic mechanisms in lower respiratory tract disease of infants due to respiratory syncytial virus

23 Human cytotoxic T cells stimulated by antigen on dendritic cells recognize the N, SH, F, M, 22K, and 1b proteins of respiratory syncytial virus

24 Cell-free and cell-bound antibody in nasal secretions from infants with respiratory syncytial virus infection

25 The 22,000-kilodalton protein of respiratory syncytial virus is a major target for Kd-restricted cytotoxic T lymphocytes from mice primed by infection

26 The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection

27 Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice

28 Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine

29 Recognition of respiratory syncytial virus fusion protein by mouse cytotoxic T cell clones and a human cytotoxic T cell line

30 Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

31 Cytotoxic T cell activity against the 22-kDa protein of human respiratory syncytial virus (RSV) is associated with a significant reduction in pulmonary RSV replication

32 Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children

33 Murine cytotoxic T cells specific to respiratory syncytial virus recognize different antigenic subtypes of the virus

34 Cytotoxic T cell specificity for respiratory syncytial virus proteins: fusion protein is an important target antigen

35 Local antibody production and respiratory syncytial virus infection in children with leukaemia

36 Virus-specific IgE and IgG4 antibodies in serum of children infected with respiratory syncytial virus

37 Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection

38 An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines

39 Cell-mediated immunity to respiratory syncytial virus induced by inactivated vaccine or by infection

40 Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G), expressed by vaccinia virus recombinants

41 Humanised monoclonal antibody to respiratory syncytial virus

42 Cytolytic T-lymphocyte responses to respiratory syncytial virus: effector cell phenotype and target proteins

43 Immunogenicity and safety of respiratory syncytial virus subunit vaccine in seropositive children 18-36 months old

44 Cytokine response to respiratory syncytial virus stimulation of human peripheral blood mononuclear cells

45 Defective regulation of immune responses in respiratory syncytial virus infection

46 Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus

47 Cytotoxic T-cell response to respiratory syncytial virus in mice

48 Immunoprophylaxis of respiratory syncytial virus infection in the infant ferret

49 The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class-specific responses

50 Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies

51 Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness

Keyword Connections

Journals

Research Groups

Bibliographies